What Biden’s Presidency Will Mean for Cancer Research
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
A new fellowship program is giving 20 early-career researchers a window into oncology drug development and the regulatory review...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
Guest post by Jennifer J. Gao, Patricia Keegan, Paul G. Kluetz, and Richard Pazdur Editor’s note: The authors all...
On April 27, cancer researchers, health care professionals, patients, advocates, and policymakers around the world logged on to their...
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
The first new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) in 2020 are for the...
The U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called fam-trastuzumab deruxtecan-nxki (Enhertu) for treating...